Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2021-07-28

Clinical Trial Update: Impact of Cannabis Oil on Nutrition in Hemodialysis Patients Study (ICON-HP Study) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating cannabis oil's impact on nutrition in hemodialysis patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cannabis oil (cannabis oil)

Snippet

Sponsor: Assaf-Harofeh Medical Center | Conditions: Protein-Energy Malnutrition, Hemodialysis | Phase 3 | Status: WITHDRAWN